Dr. Kevin Malotte's research accomplishments and extensive contributions and services in community-based research have brought national recognition to CSULB.
Currently the Archstone Foundation Endowed Chair and Director of the Center for Health Care Innovation, Dr. Malotte has been an investigator on multiple Centers for Disease Control (CDC) funded studies, including one on pre-exposure prophylaxis (PrEP) for HIV prevention.
Dr. Malotte was part of a team of researchers which conducted a study that involved giving a combined drug to heterosexual adults in Botswana to prevent HIV infection. He and his colleagues published their research, Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission, in the prestigious New England Journal of Medicine in July 2013. This was one of the studies cited by the FDA in licensing the first drug for the prevention of HIV in the United States. Dr. Malotte and his colleagues are continuing to conduct analysis on the data from this study, with his work supporting CDC behavioral scientists. He has also served as a consultant for the CDC on PrEP clinic-based counseling guidance work.
Dr. Malotte serves as the Director of CSULB's Research Infrastructure in Minority Institutions (RIMI) Project, a five-year, $4.7 million project funded by the National Institutes of Health. It has brought together faculty members and students from across the university to focus on minority health and health equity research and training. During the first few years of the project, 13 students have served as health scholars, five of whom have enrolled or been accepted in doctoral programs.
Dr. Malotte is the evaluation and learning team leader for Building Healthy Communities, Long Beach, which is committed to building a community where health care and prevention resources are available for all children, school attendance increases, the childhood obesity epidemic is reversed and youth violence is reduced. He is also working with Dr. Thomas Alex Washington (Social Work) on research funded by the National Institute on Drug Abuse that focuses on an HIV testing intervention.